Apremilast D5
| Product Name | Apremilast D5 |
|---|---|
| Alternate Names | Apremilast Stable Isotopes, Stable Isotopes of Apremilast |
| CAT No. | CS-T-48307 |
| CAS No. | 1258597-47-5 |
| Category | Stable Isotopes |
| Stock | IN-Stock |
| Mol. Wt. | 465.53 g/mol |
| Mol. For. | C₂₂H₁₉D₅N₂O₇S |
| Hazardous | This is a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Apremilast |
| Purity | 95% |
| Smileys | C[S](C[C@H](C1=CC(OC([2H])([2H])C([2H])([2H])[2H])=C(OC)C=C1)N(C(C2=CC=C3)=O)C(C2=C3NC(C)=O)=O)(=O)=O |
| Canonical Smiles | CCOC1=C(C=CC(=C1)C(CS(=O)(=O)C)N2C(=O)C3=C(C2=O)C(=CC=C3)NC(=O)C)OC |
| InchIKey | IMOZEMNVLZVGJZ-JVFKXMKASA-N |
| Inchl | InChI=1S/C22H24N2O7S/c1-5-31-19-11-14(9-10-18(19)30-3)17(12-32(4,28)29)24-21(26)15-7-6-8-16(23-13(2)25)20(15)22(24)27/h6-11,17H,5,12H2,1-4H3,(H,23,25)/t17-/m1/s1/i1D3,5D2 |
| IUPAC | N-[2-[(1S)-1-[4-methoxy-3-(1,1,2,2,2-pentadeuterioethoxy)phenyl]-2-methylsulfonylethyl]-1,3-dioxoisoindol-4-yl]acetamide |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Apremilast D5 is a deuterated form of Apremilast, an oral medication used to treat psoriasis and psoriatic arthritis. Apremilast D5 is a selective inhibitor of phosphodiesterase 4 (PDE4), which is an enzyme that regulates the levels of cyclic adenosine monophosphate (cAMP) in cells. By inhibiting PDE4, Apremilast D5 increases the levels of cAMP, leading to a reduction in inflammatory responses and the symptoms of psoriasis and psoriatic arthritis.
Apremilast D5 is administered orally, with the recommended dosage being 30mg twice a day. It is important to take Apremilast D5 as directed by a healthcare provider, and to not exceed the recommended dosage. It may take several weeks to see the full benefits of Apremilast D5, and it should be taken consistently to maintain its effectiveness.
In terms of chemical information, Apremilast D5 has a molecular formula of C22H18D5N3O4, and a molecular weight of 402.49 g/mol. It is a white to off-white crystalline powder, and is stable under normal storage conditions. Apremilast D5 is not recommended for use in pregnant or breastfeeding women, as its effects on fetal development and lactation are not well understood. Additionally, it may interact with other medications, so it is important to inform your healthcare provider of all medications you are taking before starting Apremilast D5.
Get an Instant Quote
Related Compounds
Apremilast D3 | Apremilast D8 |